Researchers have identified two drugs that, when combined, may serve as an effective treatment for HIV. The two drugs, decitabine and gemcitabine — both FDA approved and currently used in pre-cancer and cancer therapy — were found to eliminate HIV infection in the mouse model by causing the virus to mutate itself to death — an outcome researchers dubbed “lethal mutagenesis.”